ScoreWhy is Haisco Pharmaceutical Group Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 2.89% and Operating profit at -12.72% over the last 5 years
2
With ROE of 10.63%, it has a very expensive valuation with a 6.94 Price to Book Value
- Over the past year, while the stock has generated a return of 45.87%, its profits have risen by 11.7%
- At the current price, the company has a high dividend yield of 1.1
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Haisco Pharmaceutical Group Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Haisco Pharmaceutical Group Co., Ltd.
-100.0%
1.55
49.00%
China Shanghai Composite
14.77%
1.01
15.10%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
2.89%
EBIT Growth (5y)
-12.72%
EBIT to Interest (avg)
4.76
Debt to EBITDA (avg)
2.08
Net Debt to Equity (avg)
0.22
Sales to Capital Employed (avg)
0.57
Tax Ratio
0.70%
Dividend Payout Ratio
117.53%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.05%
ROE (avg)
12.23%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
65
Industry P/E
Price to Book Value
6.94
EV to EBIT
177.88
EV to EBITDA
68.22
EV to Capital Employed
5.83
EV to Sales
7.29
PEG Ratio
NA
Dividend Yield
1.07%
ROCE (Latest)
3.28%
ROE (Latest)
10.63%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 499.22 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 3.84%
RAW MATERIAL COST(Y)
Fallen by -5.75% (YoY
-9What is not working for the Company
PRE-TAX PROFIT(Q)
At CNY 69.53 MM has Fallen at -48.92%
NET PROFIT(Q)
At CNY 46.72 MM has Fallen at -49.16%
DEBT-EQUITY RATIO
(HY)
Highest at 22.14 %
Here's what is working for Haisco Pharmaceutical Group Co., Ltd.
Operating Cash Flow
Highest at CNY 499.22 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Inventory Turnover Ratio
Highest at 3.84% and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -5.75% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Haisco Pharmaceutical Group Co., Ltd.
Pre-Tax Profit
At CNY 69.53 MM has Fallen at -48.92%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 46.72 MM has Fallen at -49.16%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Debt-Equity Ratio
Highest at 22.14 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
